Skip to contentM
Merit Medical Systems Inc
M
MMSIMerit Medical Systems Inc Q4 2024 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$355.16M$355.16Mderived+9.4% vs Q4 2023 Net Income$27.95M$27.95Mderived+1.2% vs Q4 2023 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Merit Medical Systems Inc · CIK 856982 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$172,983,000+14.9% Operating Incomederived$36,564,000+8.8% Operating Cash Flowderived$68,744,000+10.4% Free Cash Flowderived$65,272,000+18.4% Margins · derivedGross margin48.7%+2.3 pt vs Q4 2023
Operating margin10.3%−0.1 pt vs Q4 2023
Net margin7.9%−0.6 pt vs Q4 2023
ended Dec 31, 2024 · filed Feb 25, 2025 · 56 d after period end